# About Shop Ipamorelin: An Editorial Research Zine on Ipamorelin

> About Shop Ipamorelin — an independent editorial project summarizing the peer-reviewed research on ipamorelin. Not a clinic, not a vendor. Nothing is sold here.

An independent research zine. The name is a joke. The citations aren't.

## What this site is

Shop Ipamorelin is an independent editorial project that publishes plain-English summaries of the peer-reviewed research literature on ipamorelin. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

Let's address the name directly, because it's the whole point. The domain says "shop." There is nothing here to buy — no cart, no vendor link, no price, no affiliate funnel. The name is deliberate irony: ipamorelin is a heavily *shopped* compound, marketed hard across clinics and supplement sites, and the one thing those storefronts rarely hand you is the straight regulatory and scientific record. So we took the shopping-cart name and filled it with citations instead of products.

## Why the regulatory angle leads

Most ipamorelin content online buries the status — never FDA-approved, failed its one human trial, dropped from the 503A compounding list in 2024, banned in sport — under a wall of benefit claims. We flip that order. The regulatory record leads because it's the context that makes every other claim legible: once you know the compound is unapproved and under-studied in humans, the gap between what's marketed and what's proven becomes obvious. That's the service this zine performs — not to scare you off and not to sell you on, but to put the rules and the data where you can actually see them.

The "shop" in our name is editorial framing — a stance the publisher takes toward an over-marketed compound, not a claim that we operate a store, dispense anything, or offer treatment. We are a reading desk, not a counter.

## How we work

Every quantitative claim on the site — doses, half-lives, trial results, effect sizes — maps to a numbered, real study on the references page, drawn from PubMed, ClinicalTrials.gov, and the peer-reviewed literature. Where we lean on class-level data (studies of related peptides) we say so inline. Community-reported effects are clearly labeled as anecdotal and kept separate from cited findings. We don't recommend doses, we don't name competing brands, and we don't promise outcomes. If a claim isn't in the literature, it isn't on the site.

---

It says shop; it sells nothing — just a zine pinning ipamorelin's never-approved, pulled-from-the-503A-list, banned-in-sport record next to what the studies actually measured.